Search Our Scientific Publications & Authors

Publications
find publications by category +
Translate page:

The Influence of Lipid Excipients on Platelet Function and the Pharmacodynamic Effects of Aspirin.

Authors:
David J Schneider Heidi S Taatjes-Sommer Jayne Prats Efthymios N Deliargyris

J Cardiovasc Pharmacol 2021 Feb 19. Epub 2021 Feb 19.

Departments of Medicine, Cardiovascular Research Institute, The University of Vermont, Burlington, Vermont.

Abstract: The combination of pharmaceutical lipid excipients with aspirin in a novel liquid oral formulation (Vazalore) limits gastrointestinal toxicity of aspirin. This study was performed to determine whether the lipid excipients influence the pharmacodynamic effects of aspirin and determine whether the excipients directly affect platelet function. The pharmacodynamic effects of aspirin were assessed over a range of concentrations designed to exert limited to maximal inhibition of cyclooxygenase-1 (COX1) necessary for thromboxane A2 production. Platelet aggregation induced by arachidonic acid and assessed with the use of light transmission aggregometry (LTA) was used as a direct measure of the inhibition of COX1 by aspirin. Flow cytometry was used to assess the direct effect of excipients on platelet function. Twice the ratio of lipid excipient to aspirin used in the formulation of the novel oral agent was used. Blood was taken from 20 healthy subjects and anticoagulated with trisodium citrate (3.2%, 1:10 v/v). Aspirin and excipients were added in vitro and incubated for 10 minutes before performance of LTA and flow cytometry. The excipients did not limit the pharmacodynamic effects of aspirin. When the extent of inhibition of platelet aggregation was limited, the excipients tended to enhance pharmacodynamic effects. The excipients did not activate platelets in the absence of agonist and did not alter activation of platelets in response to adenosine diphosphate, arachidonic acid, thrombin, or convulxin (a collagen mimetic). Lipid excipients used in an oral formulation of aspirin do not impair the pharmacodynamic effects of aspirin and do not alter platelet function.

Download full-text PDF

 Source
http://dx.doi.org/10.1097/FJC.0000000000000998DOI Listing
February 2021

Publication Analysis

Top Keywords

pharmacodynamic effects
24
effects aspirin
20
platelet function
16
lipid excipients
16
aspirin
11
excipients
10
function pharmacodynamic
8
flow cytometry
8
excipients platelet
8
arachidonic acid
8
platelet aggregation
8
oral formulation
8
effects
6
pharmacodynamic
6
platelet
6
healthy subjects
4
subjects anticoagulated
4
formulation novel
4
agent blood
4
novel oral
4

Keyword Occurance

Similar Publications

Safety, Pharmacokinetics, and Pharmacodynamics of Spectrum Red Softgels in Healthy Participants.

Authors:
Erica N Peters Irina Mosesova Laura MacNair Ryan Vandrey M Hunter Land Mark A Ware Cynthia Turcotte Marcel O Bonn-Miller

J Anal Toxicol 2021 Apr 13. Epub 2021 Apr 13.

Canopy Growth Corporation, Smiths Falls, Ontario, Canada.

Due to a lack of published pharmacokinetic (PK) and/or pharmacodynamic (PD) data, informed physician and patient decision-making surrounding appropriate dosing of cannabis for medical purposes is limited. This Phase 1, multiple-dose study evaluated the safety, tolerability, PK, and PD of Spectrum Red softgels (2.5 mg Δ9-tetrahydrocannabinol (THC) and < 0. Read More

View Article and Full-Text PDF
April 2021
Similar Publications

Pharmacogenomics and Morphine.

Authors:
Adaku Ofoegbu Earl B Ettienne

J Clin Pharmacol 2021 Apr 13. Epub 2021 Apr 13.

Department of Clinical and Administrative Sciences, Howard University College of Pharmacy, 2300 4th Street, NW, Washington, District of Columbia, 20059, USA.

Morphine is an opioid analgesic indicated in the treatment of acute and chronic moderate to severe pain. From a pharmacodynamic standpoint, morphine exerts its effects by agonizing mu-opioid receptors (OPRM1) predominantly, resulting in analgesia and sedation. Pharmacokinetically, morphine is primarily metabolized in the liver via glucuronidation by the enzyme uridine diphosphate glucuronosyltransferase family 2-member B7 (UGT2B7) and encounters the transporter proteins organic cation transporter isoform 1 (OCT1) and p-glycoprotein (ABCB1) as it is being distributed throughout the body. Read More

View Article and Full-Text PDF
April 2021
Similar Publications

Impact of extreme weight loss on factor VIII concentrate pharmacokinetics in haemophilia.

Authors:
Iris van Moort Laura H Bukkems Laurens Nieuwenhuizen Marjon H Cnossen

BMJ Case Rep 2021 Apr 12;14(4). Epub 2021 Apr 12.

Department of Paediatric Haematology, Erasmus University Medical Center-Sophia Childrens Hospital Rotterdam, Rotterdam, The Netherlands

We explored the effects of extreme weight loss after gastric bypass surgery on factor VIII concentrate pharmacokinetic (PK) parameters in a patient with haemophilia A. We present a 32-year-old man with severe haemophilia A, with a body mass index (BMI) of 42.6 kg/m who underwent laparoscopic sleeve gastrectomy. Read More

View Article and Full-Text PDF
April 2021
Similar Publications

Caspofungin pharmacokinetics and probability of target attainment in ICU patients in China.

Authors:
Fangyi Li Minggen Zhou Zheng Jiao Zijun Zou Erqian Yu Zhijie He

J Glob Antimicrob Resist 2021 Apr 9. Epub 2021 Apr 9.

Department of intensive care unit, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China. Electronic address:

Background: Effective antifungal therapy is important for reducing the mortality of patients with invasive fungal diseases. Numerous factors affect the pharmacokinetic (PK)/pharmacodynamic (PD) parameters in critically ill patients. To guide the individualized administration of the antifungal drug caspofungin in critically ill patients, it is of great significance to investigate the population pharmacokinetics of caspofungin. Read More

View Article and Full-Text PDF
April 2021
Similar Publications

Automated blood sampling in canine telemetry studies: Enabling enhanced assessments of cardiovascular liabilities and safety margins.

Authors:
Yevgeniya E Koshman Amanda S Wilsey Brandan M Bird Sabine Sadilek Debra A Weisbecker Paige A Ebert James S Polakowski Gary A Gintant Scott W Mittelstadt C Michael Foley

J Pharmacol Toxicol Methods 2021 Apr 7:107066. Epub 2021 Apr 7.

AbbVie Inc., 1 North Waukegan Rd., North Chicago, IL 60064, United States of America.

Introduction: A successful integration of automated blood sampling (ABS) into the telemetry instrumented canine cardiovascular model is presented in this study. This combined model provides an efficient means to quickly gain understanding of potential effects on key cardiovascular parameters in dog while providing a complete Pharmacokinetic/Pharmacodynamic (PK/PD) profile for discovery compounds without handling artifacts, reducing the need for a separate pharmacokinetic study.

Methods: Male beagle dogs were chronically implanted with telemetry devices (PhysioTel™ model D70-PCTP) and vascular access ports (SPMID-GRIDAC-5NC). Read More

View Article and Full-Text PDF
April 2021
Similar Publications